Menu
 
Research menu
Jump to menu

Publications:  Dr Steven Coppen

Sawhney V, Brouilette S, Campbell N, Coppen S, Baker V, Hunter R, Dhinoja M, Johnston A et al.(2018). Association of genetic variation in telomere-related SNP and telomerase with ventricular arrhythmias in ischemic cardiomyopathy. PACE - Pacing and Clinical Electrophysiology vol. 41, (3) 261-266.
10.1111/pace.13284
https://qmro.qmul.ac.uk/xmlui/handle/123456789/44809
SUZUKI K, Campbell N, Mathur A(2016). Cell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from A Rat Model. PLoS One vol. 11, (7) Article e0158232,
10.1371/journal.pone.0158232
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13418
Sawhney V, Campbell NG, Brouilette SW, Coppen SR, Harbo M, Baker V, Ikebe C, Shintani Y et al.(2016). Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia. International Journal of Cardiology vol. 207, 157-163.
10.1016/j.ijcard.2016.01.066
Tano N, Kaneko M, Ichihara Y, Ikebe C, Coppen SR, Shiraishi M, Shintani Y, Yashiro K et al.(2016). Allogeneic mesenchymal stromal cells transplanted onto the heart surface achieve therapeutic myocardial repair despite immunologic responses in rats. Journal of the American Heart Association vol. 5, (2)
10.1161/JAHA.115.002815
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12778
Kokkinopoulos I, Ishida H, Saba R, Ruchaya P, Cabrera C, Struebig M, Barnes M, Terry A et al.(2015). Single-cell expression profiling reveals a dynamic state of cardiac precursor cells in the early mouse embryo. PLoS ONE vol. 10, (10)
10.1371/journal.pone.0140831
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13417
Sawhney VS, Brouilette SW, Campbell NG, Coppen SR, Baker VB, Hunter RJ, Dhinoja MD, Earley MJ et al.(2014). 23Association of TERC related genetic variation and telomerase activity with ventricular arrhythmias in ischaemic cardiomyopathy. Europace vol. 16 Suppl 3,
10.1093/europace/euu238.5
Tano N, Narita T, Kaneko M, Ikebe C, Coppen SR, Campbell NG, Shiraishi M, Shintani Y et al.(2014). Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. Mol Ther vol. 22, (10) 1864-1871.
10.1038/mt.2014.110
Shintani Y, Drexler HCA, Kioka H, Terracciano CMN, Coppen SR, Imamura H, Akao M, Nakai J et al.(2014). Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep vol. 15, (4) 438-445.
10.1002/embr.201337945
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12787
Tano N, Narita T, Kaneko M, Ikebe C, Coppen SR, Campbell NG, Shiraishi M, Shintani Y et al.(2014). Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; In vivo proof-of-concept study. Molecular Therapy vol. 22, (10) 1864-1871.
10.1038/mt.2014.110
Tano N, Kaneko M, Ikebe C, Coppen SR, Shiraishi M, Shintani Y, Suzuki K (2013). Scaffold Free "Cell Sheets" Composed of Mesenchymal Stromal Cells for the Treatment of Chronic Heart Failure; In Viveo Proof-of-Concept Study. CIRCULATION. vol. 128,
Tano N, Kaneko M, Ikebe C, Coppen SR, Shiraishi M, Shintani Y, Suzuki K (2013). The Use of Allogeneic Mesenchymal Stromal Cells to Refine the Emerging "Cell-Sheet" Technique for the Treatment of Heart Failure. CIRCULATION. vol. 128,
Narita T, Shintani Y, Ikebe C, Kaneko M, Harada N, Tshuma N, Takahashi K, Campbell NG et al.(2013). The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblast-based therapy to the heart with enhanced therapeutic effects. Int J Cardiol vol. 168, (1) 261-269.
10.1016/j.ijcard.2012.09.081
Narita T, Shintani Y, Ikebe C, Kaneko M, Campbell NG, Coppen SR, Uppal R, Sawa Y et al.(2013). The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure. Mol Ther vol. 21, (4) 860-867.
10.1038/mt.2013.9
Shintani Y, Kapoor A, Kaneko M, Smolenski RT, D'Acquisto F, Coppen SR, Harada-Shoji N, Lee HJ et al.(2013). TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons. Proc Natl Acad Sci U S A vol. 110, (13) 5109-5114.
10.1073/pnas.1219243110
Kaneko M, Shintani Y, Narita T, Ikebe C, Tano N, Yamahara K, Fukushima S, Coppen SR et al.(2013). Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure. PLoS One vol. 8, (10)
10.1371/journal.pone.0076908
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33503
Brouilette S, Kuersten S, Mein C, Bozek M, Terry A, Dias KR, Bhaw-Rosun L, Shintani Y et al.(2012). A simple and novel method for RNA-seq library preparation of single cell cDNA analysis by hyperactive Tn5 transposase. Developmental Dynamics vol. 241, (10) 1584-1590.
10.1002/dvdy.23850
Kaneko M, Shintani Y, Narita T, Ikebe C, Campbell NG, Sawhney V, Tano N, Coppen SR et al. (2012). High mobility group box 1 released from dead donor cells plays a key role in bone marrow mononuclear cell transplantation for treating heart failure. EUROPEAN HEART JOURNAL. vol. 33, 433-433.
Sawhney VS, Campbell NGC, Brouilette SWB, Shintani YS, Coppen SRC, Narita TN, Ikebe CI, Kaneko MK et al. (2012). LEUCOCYTE TELOMERE/TELOMERASE DYNAMICS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; POTENTIAL BIOMARKER FOR VENTRICULAR ARRHYTHMIAS. HEART. vol. 98, A33-A34.
10.1136/heartjnl-2012-301877b.56
Campbell NG, Kaneko M, Shintani Y, Ikebe C, Narita T, Sawhney V, Tano N, Coppen SR et al. (2012). SIZE-DEPENDENT RETENTION OF STEM CELLS FOLLOWING INTRACORONARY INJECTION. HEART. vol. 98, A67-A68.
10.1136/heartjnl-2012-301877b.119
Narita T, Shintani Y, Ikebe C, Harada N, Kaneko M, Campbell NG, Sawhney V, Coppen SR et al.(2011). Enhancing the "Paracrine Effects" of Mesenchymal Stem Cells to Recover Damaged Myocardium by the Use of Cell-Sheets. CIRCULATION vol. 124, (21)
Fukushima S, Campbell NG, Coppen SR, Yamahara K, AHY Y, Smolenski RT, Yacoub MH, Suzuki K(2011). Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. journal of Heart and Lung Transplantation vol. 30, (2) 277-233.
10.1016/j.healun.2010.09.002
Narita T, Shintani Y, Takahashi K, Campbell NG, Coppen SR, Kaneko M, Harada N, Brouilette S et al. (2010). The Use of “Cell Sheet” Technique Enhances the Therapeutic Effects of Skeletal Myoblast Transplantation with Elimination of Arrhythmogenicity. Circulation. Conference: American Heart Association (Chicago, Illinois, USA) from: 13/11/2010 to: 17/11/2010, vol. 122,
Shintani Y, Fukushima S, Varela-Carver A, Lee J, Coppen SR, Takahashi K, Brouilette SW, Yashiro K et al.(2009). Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol vol. 47, (2) 288-295.
10.1016/j.yjmcc.2009.05.009
Shintani Y, Fukushima S, Varela-Carver A, Coppen SR, Takahashi K, Brouillette SW, Salem H, Yashiro K et al. (2008). Different Paracrine Mediators and Response of the Host Myocardium by Coll Therapy: Direct Comparison between Skeletal Myoblasts and Bone Marrow Mononuclear Cells. CIRCULATION. vol. 118, S861-S861.
Coppen SR, Fukushima S, Shintani Y, Takahashi K, Varela-Carver A, Salem H, Yashiro K, Yacoub MH et al.(2008). A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation vol. 118, (14 Suppl) S138-S144.
10.1161/CIRCULATIONAHA.107.779629
Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW et al. (2008). Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation. vol. 118, S106-S114.
10.1161/CIRCULATIONAHA.107.757443
Fukushima S, Coppen SR, Lee J, Yamahara K, Felkin LE, Terracciano CMN, Barton PJR, Yacoub MH et al.(2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One vol. 3, (8)
10.1371/journal.pone.0003071
Yamahara K, Fukushima S, Coppen SR, Felkin LE, Varela-Carver A, Barton PJR, Yacoub MH, Suzuki K(2008). Heterogeneic nature of adult cardiac side population cells. BIOCHEM BIOPH RES CO vol. 371, (4) 615-620.
10.1016/j.bbrc.2008.04.021
Suzuki K, Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, Barton PJR et al.(2007). Response to letter regarding article, "Direct Intramyocardial but Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure Model". CIRCULATION vol. 116, (23) E555-E555.
10.1161/CIRCULATIONAHA.107.725937
Takahashi K, Fukushima S, Yamahara K, Coppen SR, Yacoub M, Suzuki K (2007). Controlled inflammation induced by injection of High Mobility Group Box 1 recovers post-infarction chronic failing heart. CIRCULATION. vol. 116, 573-573.
Coppen SR, Fukushima S, Varela-Carver A, Salem H, Yacoub MH, Suzuki K (2007). Downregulation of myocardial connexin43 and arrythmogenesis after injection of skeletal myoblasts but not bone marrow cells into the failing heart. CIRCULATION. vol. 116, 591-591.
Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I et al.(2007). Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun vol. 357, (4) 889-895.
10.1016/j.bbrc.2007.04.017
Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, Barton PJR, Terracciano CMN et al.(2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. CIRCULATION vol. 115, (17) 2254-2261.
10.1161/CIRCULATIONAHA.106.662577
Coppen SR, Fukushima S, Varela-Carver A, Yamahara K, Felkin LE, Ermakov A, Yacoub MH, Suzuki K (2006). Factors contributing to ventricular arrhythmias after skeletal myoblast transplantation. CIRCULATION. vol. 114, 80-80.
Yamahara K, Fukushima S, Varela-Carver A, Felkin LE, Coppen SR, Ermakov AE, Barton PJ, Yaccoub MH et al. (2006). High-mobility group box 1 protein (HMGB1) released by cell transplantation plays an important role in the therapeutic effects for treating chronic ischemic heart failure. CIRCULATION. vol. 114, 566-567.
Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lyon A, Barton PJ, Yacoub MH et al. (2006). Regardless of cell-delivery route, skeletal myoblast transplantation into chronic heart failure induces transient therapeutic effects with persistent arrhythmogenesis. CIRCULATION. vol. 114, 415-415.
Fukushima S, Yamahara K, Smolenski RT, Varela-Carver A, Coppen SR, Yuen AH, Ermakov A, Yacoub MH et al. (2006). The pattern, quantity and possible mechanism of migration of bone marrow cells into the myocardium after intracoronary injection. CIRCULATION. vol. 114, 660-661.
Varela-Carver A, Fukushima S, Coppen SR, Yamahara K, Falkin LE, Ermakov A, Barton P, Yacoub M et al. (2006). Transplantation of bone marrow cells, but not skeletal myoblasts, normalizes the downregulation of myocardial Akt in chronic heart failure. CIRCULATION. vol. 114, 415-416.
Fukushima S, Coppen SR, Varela-Carver A, Yamahara K, Sarathchandra P, Smolenski RT, Yacoub MH, Suzuki K (2006). A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. CIRCULATION. vol. 114, I251-I256.
10.1161/CIRCULATIONAHA.105.000794
Suzuki K, Fukushima S, Coppen SR, Yamahara K, Varela-Carver A, Ermakov A, Yacoub MH (2006). A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. vol. 40, 975-975.
10.1016/j.yjmcc.2006.03.163
Yamahara K, Coppen SR, Varela-Carver A, Fukushima S, Ermakov AE, Yacoub MH, Suzuki K (2006). Characterization of cardiac side population cells. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. vol. 40, 993-993.
10.1016/j.yjmcc.2006.03.215
Suzuki K, Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Ermakov A, Yacoub MH (2006). Ventricular arrhythmias induced by bone marrow cell transplantation into post-infarction chronic heart failure. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. vol. 40, 982-982.
10.1016/j.yjmcc.2006.03.183
Fukushima S, Coppen SR, Varela-Carver A, Brindley G, Yamahara K, Sarathchandra P, Yacoub MH, Suzuki K(2006). Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration. CARDIOVASC RES vol. 69, (2) 459-465.
10.1016/j.cardiores.2005.10.008
Stagg MA, Coppen SR, Suzuki K, Varela-Carver A, Lee J, Brand NJ, Fukushima S, Yacoub MH et al.(2006). Evaluation of frequency, type, and function of gap junctions between skeletal myoblasts overexpressing connexin43 and cardiomyocytes: relevance to cell transplantation. FASEB J vol. 20, (1) 744-+.
10.1096/fj.05-5088fje
Stevenson SA, Cullen MJ, Rothery S, Coppen SR, Severs NJ(2005). High-resolution en-face visualization of the cardiomyocyte plasma membrane reveals distinctive distributions of spectrin and dystrophin. Eur J Cell Biol vol. 84, (12) 961-971.
10.1016/j.ejcb.2005.09.015
Fukushima S, Coppen SR, Varela-Carver A, Sarathchandra P, Brindley G, Yamahara K, Suzuki K (2005). A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. CIRCULATION. vol. 112, U558-U558.
Fukushima S, Brindley G, Yamahara K, Coppen SR, Lee J, Varela-Carver A, Yacoub MH, Terracciano CM et al. (2005). Direct intramyocardial injection, but not intracoronary infusion of bone marrow mononuclear cells induces ventricular arrhythmias in chronic ischemic heart failure. CIRCULATION. vol. 112, U695-U695.
Coppen SR, Varela-Carver A, Stagg MA, Lee J, Fukushima S, Brand NJ, Terracciano CM, Suzuki K (2004). An investigation of gap junction formation between skeletal myoblasts and adult cardiac myocytes using myoblasts overexpressing Connexin43. CIRCULATION. vol. 110, 396-396.
Stagg MA, Coppen SR, Lee A, Varela-Carver A, Brand NJ, Fukushima S, Suzuki K, Terracciano CM (2004). Connexin43 overexpression increases gap junctional conductance between skeletal myoblasts and adult rat ventricular myocytes in coculture. CIRCULATION. vol. 110, 280-280.
Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJR, Varela-Carver A, Fukushima S, Coppen SR et al.(2004). Role of interleukin-1 beta in acute inflammation and graft death after cell transplantation to the heart. CIRCULATION vol. 110, (11) II219-II224.
10.1161/01.CIR.0000138388.55416.06
Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR, Yacoub MH(2004). Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. CIRCULATION vol. 110, (11) II225-II230.
10.1161/01.CIR.0000138191.11580.e3
Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA et al.(2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J vol. 18, (7) 1153-+.
10.1096/fj.03-1308fje
Severs NJ, Coppen SR, Dupont E, Yeh H-I, Ko Y-S, Matsushita T(2004). Gap junction alterations in human cardiac disease. Cardiovasc Res vol. 62, (2) 368-377.
10.1016/j.cardiores.2003.12.007
Severs NJ, Dupont E, Coppen SR, Halliday D, Inett E, Baylis D, Rothery S(2004). Remodelling of gap junctions and connexin expression in heart disease. Biochim Biophys Acta vol. 1662, (1-2) 138-148.
10.1016/j.bbamem.2003.10.019
Sedmera D, Reckova M, DeAlmeida A, Coppen SR, Kubalak SW, Gourdie RG, Thompson RP(2003). Spatiotemporal pattern of commitment to slowed proliferation in the embryonic mouse heart indicates progressive differentiation of the cardiac conduction system. Anat Rec A Discov Mol Cell Evol Biol vol. 274, (1) 773-777.
10.1002/ar.a.10085
Kaba RA, Li W, Coppen SR, Dupont E, Yousufuddin M, De Souza A, Pepper JR, Severs NJ (2003). Altered connexin40 expression is related to atrial dilation in patients with chronic atrial fibrillation. EUROPEAN HEART JOURNAL. vol. 24, 42-42.
10.1016/S0195-668X(03)93802-4
Kaba RA, Yacoub MH, Dupont E, Elneil S, Skepper J, Coppen SR, Pepper JR, Severs NJ (2003). Gap junctions in the atrio-ventricular conduction axis of the human heart. EUROPEAN HEART JOURNAL. vol. 24, 505-505.
10.1016/S0195-668X(03)95499-6
Sui GP, Coppen SR, Dupont E, Rothery S, Gillespie J, Newgreen D, Severs NJ, Fry CH(2003). Impedance measurements and connexin expression in human detrusor muscle from stable and unstable bladders. BJU Int vol. 92, (3) 297-305.
10.1046/j.1464-410x.2003.04342.x
Kaba RA, Coppen SR, Rothery S, Dupont E, Yacoub MH, De Souza AC, Pepper JR, Severs NJ (2003). Relevance of cardiac gap junctions to the clinical course of patients with chronic atrial fibrillation. EUROPEAN HEART JOURNAL. vol. 24, 508-508.
10.1016/S0195-668X(03)95509-6
Kaba RA, Yacoub MH, Dupont E, Sproson C, Coppen SR, Severs NJ (2003). Specific features of gap junction composition correlate with the slow and fast conduction pathways to the human atioventricular node. EUROPEAN HEART JOURNAL. vol. 24, 505-505.
10.1016/S0195-668X(03)95499-6
Halliday D, Dupont E, Coppen SR, Severs NJ (2003). Development of a cell model for functional and structural analysis of connexin co-expression: achieving homogeneous and inducible expression of multiple connexins in stable transfectants. Cell Commun Adhes. vol. 10, 311-317.
10.1080/cac.10.4-6.311.317
Kaba RA, Coppen SR, Dupont E, De Souza AC, Pepper JR, Severs NJ (2003). Connexin 43 expression is elevated in human chronic atrial fibrillation related to coronary heart disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. vol. 41, 274A-274A.
Coppen SR, Kaba RA, Halliday D, Dupont E, Skepper JN, Elneil S, Severs NJ(2003). Comparison of connexin expression patterns in the developing mouse heart and human foetal heart. Mol Cell Biochem vol. 242, (1-2) 121-127.
10.1023/A:1021150014764
Yeh H-I, Hou S-H, Hu H-R, Lee Y-N, Li J-Y, Dupont E, Coppen SR, Ko Y-S et al.(2002). Alteration of gap junctions and connexins in the right atrial appendage during cardiopulmonary bypass. J Thorac Cardiovasc Surg vol. 124, (6) 1106-1112.
10.1067/mtc.2002.124993
Fry CH, Sui GP, Coppen SR, Dupont E, Rothery S, Newgreen D, Gillespie JI, Severs NJ (2002). Intracellular resistance and connexin expression in stable and unstable human bladder smooth muscle. JOURNAL OF PHYSIOLOGY-LONDON. vol. 543, 74P-74P.
Coppen SR, Severs NJ(2002). Diversity of connexin expression patterns in the atrioventricular node: vestigial consequence or functional specialization?. J Cardiovasc Electrophysiol vol. 13, (6) 625-626.
10.1046/j.1540-8167.2002.00625.x
Kaba RA, Dupont E, Matsushita T, Coppen SR, Yacoub MH, Severs NJ(2002). Connexin40 mRNA and protein expression is elevated in end-stage human ischemic heart disease. J AM COLL CARDIOL vol. 39, (5) 283A-283A.
Kaba RA, Coppen SR, Dupont E, Skepper JN, Elneil S, Yacoub MH, Rothery S, Severs NJ(2002). Distinct expression patterns of connexins in the chambers and conduction system of the human fetal heart. J AM COLL CARDIOL vol. 39, (5) 229A-229A.
Coppen SR, Dupont E, Severs NJ(2002). Re: The sinoatrial node, connexin distribution patterns and specific immunodetection of connexin45. Cardiovasc Res vol. 53, (4) 1043-1045.
10.1016/s0008-6363(01)00564-8
Honjo H, Boyett MR, Coppen SR, Takagishi Y, Opthof T, Severs NJ, Kodama I(2002). Heterogeneous expression of connexins in rabbit sinoatrial node cells: correlation between connexin isotype and cell size. Cardiovasc Res vol. 53, (1) 89-96.
10.1016/s0008-6363(01)00421-7
Kaba RA, Dupont E, Ko YS, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ(2001). Elevated connexin40 predicts post-operative atrial fibrillation. EUR HEART J vol. 22, 152-152.
Kaba RA, Skepper JN, Coppen SR, Dupont E, Severs NJ, Elneil S(2001). Mapping connexins 45, 43 and 40 in the human foetal heart. EUR HEART J vol. 22, 56-56.
Kilarski WM, Rothery S, Roomans GM, Ulmsten U, Rezapour M, Stevenson S, Coppen SR, Dupont E et al.(2001). Multiple connexins localized to individual gap-junctional plaques in human myometrial smooth muscle. Microsc Res Tech vol. 54, (2) 114-122.
10.1002/jemt.1126
Coppen SR, Kaba RA, Gourdie RG, Skepper JN, Elneil S, Severs NJ(2001). Connexin expression in the developing mouse heart and human foetal heart. J MOL CELL CARDIOL vol. 33, (6) A23-A23.
10.1016/S0022-2828(01)90091-4
Ko YS, Coppen SR, Dupont E, Rothery S, Severs NJ(2001). Regional differentiation of desmin, connexin43, and connexin45 expression patterns in rat aortic smooth muscle. Arterioscler Thromb Vasc Biol vol. 21, (3) 355-364.
10.1161/01.atv.21.3.355
Dupont E, Ko Y, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ(2001). The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation vol. 103, (6) 842-849.
10.1161/01.cir.103.6.842
Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH et al.(2001). Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol vol. 33, (2) 359-371.
10.1006/jmcc.2000.1308
Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R et al.(2001). Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech vol. 52, (3) 301-322.
10.1002/1097-0029(20010201)52:3<301::AID-JEMT1015>3.0.CO;2-Q
Kaba RA, Coppen SR, Dupont E, Skepper JN, Elneil S, Haw MP, Pepper JR, Yacoub MH et al. (2001). Comparison of connexin 43, 40 and 45 expression patterns in the developing human and mouse hearts. Cell Commun Adhes. vol. 8, 339-343.
10.3109/15419060109080750
Coppen SR, Gourdie RG, Severs NJ(2001). Connexin45 is the first connexin to be expressed in the central conduction system of the mouse heart. Exp Clin Cardiol vol. 6, (1) 17-23.
Dupont E, Matsushita T, Vozzi C, Khan N, Coppen SR, Yacoub MH, Severs NJ(2000). Altered connexin mRNA and protein expression in human congestive heart failure. CIRCULATION vol. 102, (18) 595-595.
Return to top